These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 23344961)
1. Topoisomerase IIβ deficiency enhances camptothecin-induced apoptosis. Lin RK; Ho CW; Liu LF; Lyu YL J Biol Chem; 2013 Mar; 288(10):7182-92. PubMed ID: 23344961 [TBL] [Abstract][Full Text] [Related]
2. Topoisomerase IIbeta mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane. Lyu YL; Kerrigan JE; Lin CP; Azarova AM; Tsai YC; Ban Y; Liu LF Cancer Res; 2007 Sep; 67(18):8839-46. PubMed ID: 17875725 [TBL] [Abstract][Full Text] [Related]
3. Differences in induction of p53, p21WAF1 and apoptosis in relation to cell cycle phase of MCF-7 cells treated with camptothecin. Deptala A; Li X; Bedner E; Cheng W; Traganos F; Darzynkiewicz Z Int J Oncol; 1999 Nov; 15(5):861-71. PubMed ID: 10536167 [TBL] [Abstract][Full Text] [Related]
4. The topoisomerase IIbeta circular clamp arrests transcription and signals a 26S proteasome pathway. Xiao H; Mao Y; Desai SD; Zhou N; Ting CY; Hwang J; Liu LF Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3239-44. PubMed ID: 12629207 [TBL] [Abstract][Full Text] [Related]
5. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex. Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981 [TBL] [Abstract][Full Text] [Related]
6. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis. Hentze H; Latta M; Künstle G; Dhakshinamoorthy S; Ng PY; Porter AG; Wendel A Hepatology; 2004 May; 39(5):1311-20. PubMed ID: 15122760 [TBL] [Abstract][Full Text] [Related]
7. Topoisomerase I inhibitor, camptothecin, induces apoptogenic signaling in human embryonic stem cells. García CP; Videla Richardson GA; Romorini L; Miriuka SG; Sevlever GE; Scassa ME Stem Cell Res; 2014 Mar; 12(2):400-14. PubMed ID: 24380814 [TBL] [Abstract][Full Text] [Related]
8. Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitors. Tomicic MT; Kaina B Biochim Biophys Acta; 2013 Jan; 1835(1):11-27. PubMed ID: 23006513 [TBL] [Abstract][Full Text] [Related]
9. Tipin functions in the protection against topoisomerase I inhibitor. Hosono Y; Abe T; Higuchi M; Kajii K; Sakuraba S; Tada S; Enomoto T; Seki M J Biol Chem; 2014 Apr; 289(16):11374-11384. PubMed ID: 24573676 [TBL] [Abstract][Full Text] [Related]
10. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines. Goldwasser F; Bae I; Fornace AJ; Pommier Y Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795 [TBL] [Abstract][Full Text] [Related]
11. Topoisomerase I inhibitor (camptothecin)-induced apoptosis in human gastric cancer cells and the role of wild-type p53 in the enhancement of its cytotoxicity. Zhang ZW; Patchett SE; Farthing MJ Anticancer Drugs; 2000 Oct; 11(9):757-64. PubMed ID: 11129739 [TBL] [Abstract][Full Text] [Related]
12. Camptothecin Efficacy to Poison Top1 Is Altered by Bisphenol A in Mouse Embryonic Fibroblasts. Sonavane M; Sykora P; Andrews JF; Sobol RW; Gassman NR Chem Res Toxicol; 2018 Jun; 31(6):510-519. PubMed ID: 29799191 [TBL] [Abstract][Full Text] [Related]
13. Camptothecin induces p53-dependent and -independent apoptogenic signaling in melanoma cells. Rudolf E; Rudolf K; Cervinka M Apoptosis; 2011 Nov; 16(11):1165-76. PubMed ID: 21809047 [TBL] [Abstract][Full Text] [Related]
14. Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition. Palle K; Vaziri C Cell Cycle; 2011 May; 10(10):1625-38. PubMed ID: 21478670 [TBL] [Abstract][Full Text] [Related]
15. Target genes of Topoisomerase IIβ regulate neuronal survival and are defined by their chromatin state. Tiwari VK; Burger L; Nikoletopoulou V; Deogracias R; Thakurela S; Wirbelauer C; Kaut J; Terranova R; Hoerner L; Mielke C; Boege F; Murr R; Peters AH; Barde YA; Schübeler D Proc Natl Acad Sci U S A; 2012 Apr; 109(16):E934-43. PubMed ID: 22474351 [TBL] [Abstract][Full Text] [Related]
16. Topoisomerase I activity and sensitivity to camptothecin in breast cancer-derived cells: a comparative study. Tesauro C; Simonsen AK; Andersen MB; Petersen KW; Kristoffersen EL; Algreen L; Hansen NY; Andersen AB; Jakobsen AK; Stougaard M; Gromov P; Knudsen BR; Gromova I BMC Cancer; 2019 Nov; 19(1):1158. PubMed ID: 31783818 [TBL] [Abstract][Full Text] [Related]
17. Enhanced killing of cancer cells by poly(ADP-ribose) polymerase inhibitors and topoisomerase I inhibitors reflects poisoning of both enzymes. Patel AG; Flatten KS; Schneider PA; Dai NT; McDonald JS; Poirier GG; Kaufmann SH J Biol Chem; 2012 Feb; 287(6):4198-210. PubMed ID: 22158865 [TBL] [Abstract][Full Text] [Related]
18. Topoisomerase II inhibitor-induced apoptosis in thymocytes and lymphoma cells. Kizaki H; Onishi Y Adv Enzyme Regul; 1997; 37():403-23. PubMed ID: 9381984 [TBL] [Abstract][Full Text] [Related]
19. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells. Jacob S; Aguado M; Fallik D; Praz F Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654 [TBL] [Abstract][Full Text] [Related]
20. Deoxyguanosine enhances the cytotoxicity of the topoisomerase I inhibitor camptothecin by reducing the repair of double-strand breaks induced in replicating DNA. Squires S; Ryan AJ; Strutt HL; Smith PJ; Johnson RT J Cell Sci; 1991 Dec; 100 ( Pt 4)():883-93. PubMed ID: 1726104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]